| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/21/1998 | CN1171041A Method for producing coated tablets |
| 01/21/1998 | CN1170757A Clarifying agent and method for clarifying liquid and removing foreign matter in liquid |
| 01/21/1998 | CN1170610A Direct tabletting aids |
| 01/21/1998 | CN1170606A Compositions having inhibitive activity against 5 alpha-reductase and antibacterial activity against propionibacterium acnes |
| 01/21/1998 | CN1170601A Pure Chinese drug for curing cerebral thrambus |
| 01/21/1998 | CN1170592A External application medicinal bag for curing cancerbus ache and incision ache after operation and its preparing method |
| 01/21/1998 | CN1170591A External application medicinal bag for curing acute and chronic cholecystitis and its producing method |
| 01/21/1998 | CN1170587A Shuanghuanglian buccal-tablet made from honeysuckle flower, scutellaria root and forsythia fruit |
| 01/21/1998 | CN1170585A External application plaster for curing hepatosis and its preparing technology |
| 01/21/1998 | CN1170582A Chinese drug for curing and preventing mastosis and its preparing method |
| 01/21/1998 | CN1170581A Aerosol for curing hemorrhoids |
| 01/21/1998 | CN1170577A Method for preparing preparation made from marrow, brain, liver and blood tortoise and/or turtle and animal penis |
| 01/21/1998 | CN1037063C Preparation method for antibacterial composition of oral administration |
| 01/20/1998 | US5710183 And optionally a wetting aagent and gas reducing agent; improved bowel function |
| 01/20/1998 | US5710182 Topical solution of active agent, hydrophilic polymer, salt, wetting agent, preservative, water |
| 01/20/1998 | US5710141 Panthenol, acne |
| 01/20/1998 | US5710137 Nucleic acids and gene expression for cancer cells |
| 01/20/1998 | US5709886 Effervescent microcapsules |
| 01/20/1998 | US5709885 Process for the preparation of drug pellets |
| 01/20/1998 | US5709884 Process for conditioning substances |
| 01/20/1998 | US5709883 Solubilized in polymer matrix blend; sustained release |
| 01/20/1998 | US5709882 Pharmaceutical formulations containing a pharmacologically active ionizable substance as well as a process for the preparation thereof |
| 01/20/1998 | US5709881 Tablet capsule or granule comprising desogestrel |
| 01/20/1998 | US5709879 Vaccine compositions containing liposomes |
| 01/20/1998 | US5709877 Wound medication or covering material |
| 01/20/1998 | US5709876 Saccharide-based matrix |
| 01/20/1998 | US5709875 Calcium phosphate, dextran; promotes regeneration of bone |
| 01/20/1998 | US5709869 Intradermal delivery of lidocaine |
| 01/20/1998 | US5709868 Lipoic acid in topical compositions |
| 01/20/1998 | US5709867 Polyaromatic amide compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 01/20/1998 | US5709863 Oleic acid, azelaic acid, pimelic acid, palmitic acid |
| 01/20/1998 | US5709861 Compositions for the delivery of antigens |
| 01/20/1998 | US5709860 Induction of cytotoxic T-lymphocyte responses |
| 01/20/1998 | US5709851 Preparing a stable, aqueous iodine composition |
| 01/20/1998 | US5709848 Photocleavable metal-chelating agents and compositions containing the same |
| 01/20/1998 | US5709847 Compositions comprising a radical scavenging compound and an anti-inflammatory agent |
| 01/20/1998 | CA2066425C Apparatus for administering medicaments to mucosal tissue |
| 01/19/1998 | CA2210597A1 Buprenorphine percutaneous absorption preparation |
| 01/17/1998 | CA2210171A1 Composition comprising a hydrophilic compound and the combination of a volatile compound and a phenyl silicon oil and use of this combination |
| 01/15/1998 | WO1998001547A1 INHIBITION OF CHRONIC MYELOGENOUS LEUKEMIC CELL GROWTH BY LIPOSOMAL-ANTISENSE OLIGODEOXY-NUCLEOTIDES TARGETING TO Grb2 OR Crk1 |
| 01/15/1998 | WO1998001421A1 pH SENSITIVE HYDROGELS WITH ADJUSTABLE SWELLING KINETICS FOR COLON-SPECIFIC DELIVERY OF PEPTIDES AND PROTEINS |
| 01/15/1998 | WO1998001162A2 Gene delivery system |
| 01/15/1998 | WO1998001161A2 Gene therapy delivery system for targeting to endothelia |
| 01/15/1998 | WO1998001160A2 Compositions suitable for delivery of genes to epithelial cells |
| 01/15/1998 | WO1998001147A1 Medicinal cyclosporin-a aerosol solution formulation |
| 01/15/1998 | WO1998001146A1 Preventives/remedies for stomatitis |
| 01/15/1998 | WO1998001144A1 Antiviral agents from plant extracts and use for treatment of viral infections |
| 01/15/1998 | WO1998001139A1 Injections containing lipid a analogues and process for the preparation thereof |
| 01/15/1998 | WO1998001138A1 Methylprednisolone sodium succinate injections |
| 01/15/1998 | WO1998001124A2 Pharmaceutical preparation containing nimesulide for topical use |
| 01/15/1998 | WO1998001122A1 Solid dispersions or solid dispersion preparations of tricyclic compounds |
| 01/15/1998 | WO1998001118A1 Pharmaceutical composition for oral delivery |
| 01/15/1998 | WO1998001117A1 Sustained release matrix for high-dose insoluble drugs |
| 01/15/1998 | WO1998001115A1 Combined pharmaceutical estrogen-androgen-progestin oral contraceptive |
| 01/15/1998 | WO1998001114A1 Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug |
| 01/15/1998 | WO1998001113A1 Lubrication assistant and process for the preparation of ethyl stearate used therein |
| 01/15/1998 | WO1998001112A1 New use of a hydrogel formulation |
| 01/15/1998 | WO1998001111A1 Transdermal compositions containing levosimendan |
| 01/15/1998 | WO1998001088A1 Improved tissue injectable composition and method of use |
| 01/15/1998 | DE19629468A1 Transdermale therapeutische Systeme Transdermal therapeutic systems |
| 01/15/1998 | CA2741501A1 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to grb2 or crk1 |
| 01/15/1998 | CA2260048A1 Improved tissue injectable composition and method of use |
| 01/15/1998 | CA2259433A1 Lubrication assistant and process for the preparation of ethyl stearate used therein |
| 01/15/1998 | CA2258525A1 Combined pharmaceutical estrogen-androgen-progestin oral contraceptive |
| 01/15/1998 | CA2257408A1 Compositions suitable for delivery of genes to epithelial cells |
| 01/15/1998 | CA2257300A1 Gene therapy delivery system for targeting to endothelia |
| 01/14/1998 | EP0818204A2 Stabilized albumin-free recombinant factor VIII preparation having a low sugar contant |
| 01/14/1998 | EP0818195A1 Gelatin capsule with adjusted water activity |
| 01/14/1998 | EP0818194A2 Lubricant compositions that are spreadable onto and adherable to biomembranes, method of making and use thereof |
| 01/14/1998 | EP0817791A1 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis |
| 01/14/1998 | EP0817655A1 Intrapulmonary delivery of hematopoietic drug |
| 01/14/1998 | EP0817645A1 Method for treatment of benign prostatic hypertrophy |
| 01/14/1998 | EP0817643A1 Compounds and compositions for delivering active agents |
| 01/14/1998 | EP0817638A2 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers |
| 01/14/1998 | EP0817634A1 Azathioprine compositions for colonic administration |
| 01/14/1998 | EP0817633A1 Transdermal device for the delivery of alfuzosin |
| 01/14/1998 | EP0817628A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 01/14/1998 | EP0817626A2 Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections |
| 01/14/1998 | EP0817622A1 Medicament with angiotensin converting enzyme (ace) inhibitors suitable for transdermal application |
| 01/14/1998 | EP0817621A1 Pharmaceutical composition for transdermic delivery |
| 01/14/1998 | EP0817620A1 Nanospheres comprising a biocompatible polysaccharide |
| 01/14/1998 | EP0817619A1 Novel "burst-free" sustained release poly-(lactide/glycolide) mi crospheres |
| 01/14/1998 | EP0817618A1 Soft gelatin capsule with a gelatin shell comprising xanthine derivative |
| 01/14/1998 | EP0817617A1 Microcapsules of predetermined peptide(s) specificity(ies), their preparation and uses |
| 01/14/1998 | EP0817616A1 Pharmaceutical matrix pellets, tablets and composition for the preparation thereof |
| 01/14/1998 | EP0817615A2 Peroral composition for controlled release in the lower gastrointestinal tract |
| 01/14/1998 | EP0817614A1 Stable protein:phospholipid compositions and methods------------ |
| 01/14/1998 | EP0817613A1 Use of compositions comprising stabilized biologically effective compounds |
| 01/14/1998 | EP0817612A1 Transparent rapid-release preparations of non-steroid analgesics |
| 01/14/1998 | EP0817611A1 Butixocort aerosol formulations |
| 01/14/1998 | EP0817610A1 Sterile ophthalmological gel preparation applicable in drops and process for producing it |
| 01/14/1998 | EP0671901B1 Compositions for dispensing fragrances |
| 01/14/1998 | EP0578796B1 Device for dispensing a medicament |
| 01/14/1998 | EP0548088B1 Method of producing semi-solid preparations containing micro-particulate substances |
| 01/14/1998 | CN1170392A Packaging for patches |
| 01/14/1998 | CN1170364A Liposome eye drops |
| 01/14/1998 | CN1170361A Therapeutic perparation for inhalation containing parathyroid hormone, PTH |
| 01/14/1998 | CN1170360A Transdermal delivery system with adhesive overlay and peel seal disc |
| 01/14/1998 | CN1170359A Transdermal system for the simultaneous delivery of a number of active principles |
| 01/14/1998 | CN1170358A Chewable dosage forms |